This trial is active, not recruiting.

Condition ecmo and acute mi
Sponsor Johann Wolfgang Goethe University Hospitals
Start date January 2003
End date December 2006
Trial size 60 participants
Trial identifier NCT00425685, ECMO and AMI, Use of ECM in acute MI


ECMO offers an acceptable cardiopulmonary support in adults with similar hospital survival rates as other mechanical support. It is versatile and salvages some patients, who may otherwise die. Improvement in intermediate term outcome will require multidisciplinary approach to protect organ function and limit organ injury during this support.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Observational model defined population
Primary purpose screening
Time perspective longitudinal

Eligibility Criteria

Male or female participants from 17 years up to 90 years old.

Inclusion Criteria: - Acute MI Exclusion Criteria: - Contraindication against ECMO

Additional Information

Official title Use of Extracorporeal Membrane Oxygenation in Treatment of Acute Myocardial Infarction Following Cardiac Surgery Procedures
Principal investigator Farhad Bakhtiary, MD
Description Extracorporeal membrane oxygenation (ECMO) is an established treatment option in patients with Cardiogenic Schock. We retrospectively reviewed early and mid-term outcome as well as predictors of survival during using ECMO. This report reviews our experience with this support system in last 3 years.
Trial information was received from ClinicalTrials.gov and was last updated in January 2007.
Information provided to ClinicalTrials.gov by Johann Wolfgang Goethe University Hospitals.